April 2024
BIOPHARMA / IMMUNO-ONCOLOGY / AACR 2024: Immuno-Oncology (IO) Round-up
View research noteMarch 2024
Healthcare / The Auto Cell Therapy Manufacturing Opportunity: Lowering CoGS & Driving Scale
View research noteFebruary 2024
Biopharma / Beyond Incretins: Evaluating Alternative Mechanisms in Obesity
View research noteJanuary 2024
Biopharma / Will ASPEN Send it or Huck and Pray? Previewing Big Brensocatib Binary in 2Q24
View research noteDecember 2023
Biopharma / ASH: Anito-cel Ph 1 Outcomes Are Strong, Swings in Expectations Pressure ACLX
View research noteNovember 2023
Biopharma / Emerging Large Biopharma Interest in CNS
View research noteOctober 2023
Biopharma / Takeaways from Our Pre-ESMO Lung Cancer Pulse Call
View research noteSeptember 2023
Biopharma / Bullish on the CAH Opportunity
View research noteAugust 2023
Biopharma / Immuno-Oncology / Debates & Questions After the Positive OS Trend with Roche’s TIGIT in SKY-01
View research noteJuly 2023
Biopharma / Diversified Biopharmaceuticals / JNJ — Flash / Oral IL-23 BID Efficacy Similar to Stelara but Below Injectable IL-23s / Outperform
View research noteJune 2023
Biopharma / ASCO Single-Agent Responses with IO, but Context Matters for BOLT, IPHA, AFMD
View research noteMay 2023